Physician profile
Ronald Hurst
NPI 1619069820
$76,062.29
in general payments reported to CMS, 2019-2025
14 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $226 · 2021: $4,906 · 2022: $13K · 2023: $4,200 · 2024: $8,408 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $23K · Food and Beverage: $1,449 · Travel and Lodging: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $22,750.00 |
| Food and Beverage | $1,449.05 |
| Travel and Lodging | $1,257.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $75,115.99 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $341.76 | 2020-2021 | |
| Boston Scientific Corporation | $149.02 | 2019 | |
| Becton, Dickinson and Company | $112.06 | 2019 | |
| Ethicon US, LLC | $63.59 | 2020-2021 | |
| Merit Medical Systems INC | $54.44 | 2024 | Savi Scout |
| Biom'Up France Sas | $46.12 | 2020-2021 | |
| Covidien Lp | $44.64 | 2019 | |
| Conmed Corporation | $43.19 | 2021 | |
| Averitas Pharma INC. | $23.08 | 2023 | Qutenza |
| Leica Microsystems INC. | $21.83 | 2020 | |
| Merck Sharp & Dohme LLC | $17.73 | 2019 | |
| Myriad Genetic Laboratories, INC. | $15.77 | 2023 | Myrisk |
| Convatec INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hurst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.